In Vitro Tumor Microenvironment Model Using Shear Stress

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional in vitro tumor models fail to accurately mimic the in vivo tumor microenvironment, leading to poor prediction of anticancer therapy efficacy and safety due to the lack of representation of key components and interactions present in vivo.

Innovation Solution

A method is developed to mimic the tumor microenvironment in vitro by adding a culture medium to a cell culture container, plating tumor cells, and applying shear stress using a flow device, which recreates the dynamic flow conditions similar to those in vivo, allowing for the inclusion of extracellular matrix and co-culture with endothelial and stromal cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If conventional in vitro models use static monocultures of tumor cells, then the model simplicity and ease of operation are improved, but the accuracy of mimicking in vivo tumor microenvironment and prediction of drug efficacy deteriorates

Engineering Contradiction:
Improveease of operationVSAvoidaccuracy of mimicking in vivo tumor microenvironment
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The in vitro model is segmented into multiple distinct cell types (tumor cells, endothelial cells, stromal cells) that are cultured separately and then combined, allowing each cell type to be optimized independently while maintaining overall system complexity that mimics the in vivo tumor microenvironment

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The model transitions from two-dimensional static monoculture to three-dimensional co-culture systems with multiple cell types and spatial arrangements, adding dimensional complexity that better represents the heterogeneous in vivo tumor microenvironment while improving predictive accuracy

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Device complexity

If conventional in vitro models are used under static conditions, then the device complexity and operational simplicity are improved, but the reliability of predicting drug sensitivity in vivo deteriorates

Engineering Contradiction:
Improvedevice complexityVSAvoidreliability of predicting drug sensitivity
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The model incorporates dynamic flow conditions through bioreactors or perfusion systems that simulate blood flow patterns, creating dynamic mechanical stimuli and nutrient delivery that mimic in vivo conditions, thereby improving the reliability of drug sensitivity predictions without excessive complexity

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

Hydraulic flow systems are introduced to deliver culture medium and apply shear stress to cells in a controlled manner, simulating physiological blood flow conditions and improving the physiological relevance of the model while maintaining manageable device complexity

Inventive Principle:
Principle #29Pneumatics and hydraulics

3Ease of operation

If conventional in vitro models require much higher concentrations of drug to induce response, then the operational simplicity is maintained, but the accuracy of predicting in vivo drug response and safety deteriorates

Engineering Contradiction:
Improveease of operationVSAvoidaccuracy of predicting in vivo drug response
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

Endothelial cells and stromal cells are introduced as intermediary cell types that mediate the interaction between tumor cells and drugs, recreating the protective and modulating effects of the tumor microenvironment that alter drug pharmacokinetics and pharmacodynamics, thereby improving prediction of in vivo drug response at clinically relevant concentrations

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the accuracy of preclinical screening for anticancer agents by more closely replicating in vivo conditions, improving the prediction of drug sensitivity and safety, and allowing for the assessment of tumor growth, proliferation, and metastasis.

Implementation Method 1

indirectly applying a shear stress upon the at least one tumor cell type, the shear stress resulting from flow of the culture medium induced by a flow device

Methodology Applied
Scientific EffectShear stress: Shear Stress

Data Source

PatentEP3060654B1In vitro model for a tumor microenvironment
Publication Date: 2023.03.15 HEMOSHEAR LLC
  • EP3060654B1 patent drawingFigure 1
  • EP3060654B1 patent drawingFigure 2
  • EP3060654B1 patent drawingFigure 3

AI summary

Methods for mimicking a tumor microenvironment in vitro are provided. The methods comprise indirectly applying a shear stress upon at least one tumor cell type plated on a surface within a cell culture container. Methods for mimicking tumor metastasis and methods for testing drugs or compounds in such systems are also provided.